Outcomes of interest | Studies, no | off-PN patients, no | on-PN patient, no | WMD/OR (95%CI) | p value | Study heterogeneity | |||
---|---|---|---|---|---|---|---|---|---|
Chi2 | df | p value | I2,% | ||||||
Primary outcomes | |||||||||
 short-term change of eGFR | 10 | 340 | 927 | 4.81(3.53,6.08) | < 0.00001 | 9.65 | 9 | 0.38 | 7 |
 short-term change of Cr level | 10 | 270 | 536 | −0.05(− 0.09,-0.00) | 0.04 | 9.29 | 9 | 0.41 | 3 |
 long-term change of eGFR | 11 | 745 | 1296 | 1.26(0.04,2.48) | 0.04 | 16.63 | 10 | 0.08 | 40 |
 long-term % change of eGFR | 8 | 673 | 1166 | 2.52(1.53,3.50) | < 0.00001 | 1.13 | 7 | 0.99 | 0 |
 long-term change of Cr level | 3 | 250 | 351 | −0.04(−0.13, 0.05) | 0.40 | 5.47 | 2 | 0.07 | 63 |
Secondary outcomes | |||||||||
 long-term eGFR | 9 | 582 | 1040 | −0.18(−3.89,3.53) | 0.92 | 37.54 | 8 | < 0.00001 | 79 |
 short-term eGFR | 9 | 327 | 915 | 9.72(6.13,13.30) | < 0.00001 | 43.70 | 8 | < 0.00001 | 82 |
 short-term Cr level | 7 | 237 | 452 | −0.08(−0.13,-0.02) | 0.007 | 2.23 | 6 | 0.90 | 0 |
 increase in CKD(stage≥3) | 5 | 170 | 522 | 0.73(0.39,1.39)a | 0.34 | 0.97 | 4 | 0.91 | 0 |
 postoperative AFR | 3 | 224 | 568 | 0.25(0.10,0.63)a | 0.003 | 0.10 | 2 | 0.95 | 0 |